Description of Tolerability of LCZ696 (Sacubitril / Valsartan) in Heart Failure With Reduced Ejection Fraction (HFrEF) Treated in Real Life Setting
Clinical trial NCT02690974 · COMPLETED
Trial details
- NCT number
- NCT02690974
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-08
- Primary completion
- 2017-06-07
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.